Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.8000 (1.17%) ($13.2700 - $14.1000) on Wed. Jul. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.79% (three month average) | RSI | 61 | Latest Price | $13.8000(1.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.395% in a week (0% probabilities). VIXM(-32%) VXX(-26%) XLC(-9%) UUP(-9%) UNG(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.395% (StdDev 6.79%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
5 Day Moving Average | $14.19(-2.75%) | 10 Day Moving Average | $14.67(-5.93%) | 20 Day Moving Average | $13.67(0.95%) | To recent high | -11% | To recent low | 74.2% | Market Cap | $1.025b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |